Storing GLP-1 Medications Safely on the Go One challenge for people taking GLP-1 medications is keeping them at the right temperature while traveling, commuting, or on busy days
In its lawsuit, the OFA said that the FDAs decision to end the shortage was a reckless and arbitrary move and could deprive patients of a vital treatment for type 2 diabetes and obesity. In an interview with BioSpace last month, David Rosen, partner at Foley & Lardner, said that the lawsuit is a precedent in this area. Prior to the OFA suit, no one has ever challenged the FDAs decision to remove a therapy from the drug shortage list. The OFA case is still ongoing, with the next court update due on Thursday
Otras resoluciones: 250 444 pxeles 960 1707 pxeles
However, sustained weight loss proves difficult for many people
Consider switching to abdominal injections where the fat layer is typically thicker, or speak with your provider about needle length options
Today, that conversation is evolving and Read Article